Skip to main content

Table 4 Association between inflammatory marker measurement at Tanner 2 and Tanner 4 with relative time to menarche

From: Association between indicators of systemic inflammation biomarkers during puberty with breast density and onset of menarche

Inflammatory marker

Breast Tanner stage

N

EventsD

Relative time to menarche per doubling of inflammatory marker; time ratio (95% CI)

Age-adjusted modelA

 CRP

Tanner 2

348

302

1.00 (0.99–1.00)

Tanner 4

298

291

1.01 (1.00–1.01)***

 IL-6

Tanner 2

381

335

0.99 (0.99–1.00)*

Tanner 4

298

291

1.00 (1.00–1.01)

 TNFR2

Tanner 2

381

335

0.97 (0.95–0.99)*

Tanner 4

298

291

1.00 (0.98–1.02)

Age and body fatness-adjusted modelB

 CRP

Tanner 2

347

301

1.00 (0.99–1.00)

Tanner 4

298

291

1.01 (1.00–1.01)***

 IL-6

Tanner 2

380

334

0.99 (0.99–1.00)*

Tanner 4

298

291

1.00 (0.99–1.01)

 TNFR2

Tanner 2

380

334

0.97 (0.95–1.00)*

Tanner 4

298

291

1.00 (0.98–1.01)

Multivariable-adjusted modelC

 CRP

Tanner 2

336

291

1.00 (0.99–1.00)

Tanner 4

291

284

1.01 (1.00–1.01)***

 IL-6

Tanner 2

369

324

0.99 (0.98–1.00)**

Tanner 4

291

284

1.00 (0.99–1.01)

 TNFR2

Tanner 2

369

324

0.98 (0.96–1.00)*

Tanner 4

291

284

1.00 (0.98–1.02)

  1. AAccelerated failure time model for time to menarche from birth adjusting for age at inflammatory biomarker measurement
  2. BModel adjusting for age at inflammatory biomarker measurement and fat percentage at biomarker measurement
  3. CModel adjusting for age at inflammatory biomarker measurement, fat percentage at biomarker measurement, ethnicity, birth weight, height age- and sex-specific Z-score, and maternal education
  4. DNumber of girls reaching menarche during follow-up period
  5. *p < 0.05
  6. **p < 0.01
  7. ***p < 0.001